Gilead
Investors
Investors
Innovation in every aspect of our business has enabled us to develop best-in-class therapeutics and to successfully commercialize them worldwide.
Investor Disclaimer



Webcast ImageWebcast
Thomas Weisel Partners Healthcare Conference (Replay)
09/03/08 at 10:55 a.m. ET
Thomas Weisel Partners Healthcare Conference
Wednesday, September 3, 2008 12:00 p.m.  through Friday, September 5, 2008 
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Listen to the Webcast in Real Player Click here for webcast

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
GILD (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$47.85
Change (%) Stock is Down 2.13 (4.26%)
Volume12,800,590
Data as of 09/05/08 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

More >>
DateTitle 
08/27/08Gilead Sciences to Present at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 3Printer Friendly Version
08/11/08U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in AdultsPrinter Friendly Version
08/01/08Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve CountriesPrinter Friendly Version

Upcoming Events

More >>
DateTitle
09/16/08
through
09/18/08
Merrill Lynch Global Pharmaceutical Biotech & Medical Devices Conference
LocationLondon
09/22/08
through
09/25/08
UBS Global Life Sciences Conference
LocationNew York, NY

Most Viewed Links

Updated 09/06/08
1.Stock Quote
2.Annual Reports
3.SEC Filings
4.Corporate Governance - Highlights
5.Fundamentals - Snapshot
* Data collected 08/16/08 - 08/23/08

Receive E-mail Alerts

E-mail Alert Icon
Sign up to receive e-mail alerts whenever Gilead Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.